M. Farao
- Co-authors
- Maria GrandiAntonino SuaratoEnrico PesentiF. SpreaficoMarina RipamontiLeonard W. SeymourKarel UlbrichVladimír Šubr
- Topics
- Cancer therapeutics and mechanisms (3 papers)Bioactive Compounds and Antitumor Agents (2 papers)Nanoparticle-Based Drug Delivery (2 papers)
- Cited by
- BiomaterialsOncologyToxicology
- Journals
- Journal of Controlled ReleaseBritish Journal of CancerBioorganic & Medicinal Chemistry Letters
- Partner nations
- ItalyUnited KingdomCzechia
In The Last Decade
M. Farao
9 papers receiving 386 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 236
- Biomaterials 166
- Oncology 128
- Organic Chemistry 72
- Biomedical Engineering 72
Countries citing papers authored by M. Farao
This map shows the geographic impact of M. Farao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Farao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Farao more than expected).
Fields of papers citing papers by M. Farao
This network shows the impact of papers produced by M. Farao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Farao. The network helps show where M. Farao may publish in the future.
Co-authorship network of co-authors of M. Farao
This figure shows the co-authorship network connecting the top 25 collaborators of M. Farao. A scholar is included among the top collaborators of M. Farao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Farao. M. Farao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 135 | |
| 2 | 8 | |
| 3 | 24 | |
| 4 | 3 | |
| 5 | FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis. | 16 |
| 6 | Inhibition of lung and liver tumor colonies in mice pretreated with suramin. | 7 |
| 7 | 44 | |
| 8 | 158 | |
| 9 | 4 |
About M. Farao
M. Farao is a scholar working on Toxicology, Oncology and Biophysics, having authored 9 papers that have together received 399 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (166 citations), Oncology (128 citations) and Toxicology (14 citations). M. Farao has collaborated with scholars based in Italy, United Kingdom and Czechia. Frequent co-authors include Maria Grandi, Antonino Suarato, Enrico Pesenti, F. Spreafico, Marina Ripamonti, Leonard W. Seymour, Karel Ulbrich, Vladimír Šubr, Stephen R. Wedge and Isabella C. Hume. Their work appears in journals such as Journal of Controlled Release, British Journal of Cancer and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.